Pharmaceutical - Diabetes, Pharmaceutical

Filter

Current filters:

DiabetesPharmaceutical

Popular Filters

1 to 25 of 405 results

Erectile dysfunction and diabetes drugs to be tested as dementia treatments

Erectile dysfunction and diabetes drugs to be tested as dementia treatments

12-12-2014

The Alzheimer's Drug Discovery Foundation (ADDF) and the Alzheimer's Society UK announced new funding…

CialisDiabetesEli LillyliraglutideMen's HealthNeurologicalNovo NordiskPharmaceuticalResearchTadalafilVictoza

Patient access to novel non-insulin treatments is sub-optimal in China

05-12-2014

With respect to the treatment of type 2 diabetes in China, patient access to premium-priced agents is…

AstraZenecaByettaChinaDiabetesHealthcareJanuviaMarkets & MarketingMerck & CoPharmaceutical

Eli Lilly's Trulicity approved in the EU for type 2 diabetes

Eli Lilly's Trulicity approved in the EU for type 2 diabetes

26-11-2014

US drug major Eli Lilly has received approval from the European Commission for its GLP-1 receptor agonist…

DiabetesEli LillyEuropePharmaceuticalRegulationTrulicity

Merck & Co submits first regulatory filing for omarigliptin, in Japan

Merck & Co submits first regulatory filing for omarigliptin, in Japan

25-11-2014

US pharma giant Merck & Co has submitted a new drug application for omarigliptin, its investigational…

DiabetesJapanMerck & CoomarigliptinPharmaceuticalRegulation

CHMP positive opinion on Victoza in type 2 diabetes patients with moderate renal impairment

CHMP positive opinion on Victoza in type 2 diabetes patients with moderate renal impairment

21-11-2014

The European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive…

DiabetesEuropeNovo NordiskPharmaceuticalRegulationVictoza

Sanofi showcases next wave of medicines and vaccines

20-11-2014

French pharma major Sanofi is today outlining its intention to launch high-potential new medicines and…

Cardio-vascularDiabetesHealth Medical PharmaImmunologicalsNeurologicalPharmaceuticalPharmaceutical industryRare diseasesResearchSanofiUnited StatesVaccines

UK diabetes patients being denied vital prescriptions for testing strips

19-11-2014

Patients in Britain with diabetes are missing out on vital prescriptions that let them keep tabs on their…

DiabetesHealthcarePharmaceuticalUK

Added benefit of Jardiance not proven, says IQWiG

19-11-2014

Following an examination as to whether Jardiance (empagliflozin) offers an added benefit over appropriate…

Boehringer IngelheimDiabetesEli LillyGermanyJardiancePharmaceuticalPricingRegulation

International Diabetes Federation releases focus on Middle East

14-11-2014

The International Diabetes Federation has published its sixth Diabetes Atlas with a particular focus…

DiabetesMiddle EastPharmaceuticalResearchRest of the World

SMC accepts Eylea and Onglyza for use in NHS Scotland

SMC accepts Eylea and Onglyza for use in NHS Scotland

13-11-2014

The Scottish Medicines Consortium (SMC) has accepted German drugmaker Bayer’s Eylea (aflibercept solution…

AstraZenecaBayerDiabetesEyleaOnglyzaPharmaceuticalRegulationUK

New Phase IIIa data further demonstrate benefits of liraglutide in obesity

04-11-2014

Positive new data from the Phase IIIa SCALE Obesity and Prediabetes trial were presented today at Obesity…

DiabetesliraglutideMetabolicsNovo NordiskPharmaceuticalResearchSaxendaVictoza

Novo Nordisk and Roche Diabetes Care launch new treatment option

Novo Nordisk and Roche Diabetes Care launch new treatment option

03-11-2014

Danish diabetes care giant Novo Nordisk has today launched NovoRapid PumpCart, the first pre-filled pump…

DiabetesMarkets & MarketingNovo NordiskNovoRapidPharmaceuticalRocheSwitzerland

Novo Nordisk begins building $130 million lab facility in Denmark

Novo Nordisk begins building $130 million lab facility in Denmark

31-10-2014

Danish insulin giant Novo Nordisk has made a 750 million Danish kroner ($130 million) investment in new…

DenmarkDiabetesNovo NordiskPharmaceuticalProduction

US FDA approves AstraZeneca’s Xigduo XR

US FDA approves AstraZeneca’s Xigduo XR

30-10-2014

The US Food and Drug Administration has approved Anglo-Swedish pharma major AstraZeneca’s once-daily…

AstraZenecaDiabetesPharmaceuticalRegulationUSAXigduo XR

Novo Nordisk posts strong results, reassures with guidance

Novo Nordisk posts strong results, reassures with guidance

30-10-2014

Global diabetes care giant, Denmark’s Novo Nordisk saw its shares gain 4% to 265.80 Danish kroner this…

DiabetesFinancialNovo NordiskPharmaceutical

Boehringer Ingelheim and Lilly revise diabetes alliance in certain countries

29-10-2014

In a move that will strengthen their 2011 alliance by enhancing efficiencies and enabling greater focus…

Boehringer IngelheimDiabetesEli LillyJardianceJentaduetoLicensingMarkets & MarketingPharmaceuticalTrajenta

Takeda and Lilly’s fine is reduced in Actos case

Takeda and Lilly’s fine is reduced in Actos case

28-10-2014

A US district court has reduced the damages to be paid by Japan’s largest drugmaker Takeda Pharmaceutical…

ActosDiabetesEli LillyLegalPharmaceuticalTakeda PharmaceuticalUSA

Novo Nordisk subpoenaed by US Attorney

Novo Nordisk subpoenaed by US Attorney

25-10-2014

Danish diabetes care giant Novo Nordis on Friday revealed it had been served with a subpoena by the office…

DenmarkDiabetesLegalNovo NordiskPharmaceuticalProductionUSA

Actavis signs option to acquire relamorelin developer

Actavis signs option to acquire relamorelin developer

22-10-2014

Ireland-headquartered Actavis has been granted an exclusive option to acquire USA-based biopharma company…

ActavisDiabetesGastro-intestinalsIrelandMergers & AcquisitionsPharmaceuticalrelamorelinRhythm Health

Ferring Pharma regains rights to DDAVP portfolio

Ferring Pharma regains rights to DDAVP portfolio

22-10-2014

Privately-held Switzerland-headquartered Ferring Pharmaceuticals says it has acquired DDAVP (desmopressin…

DDAVPDiabetesFerring PharmaceuticalsGenito-urinaryLicensingPharmaceuticalSanofiSwitzerland

Physicians in South Korea and Taiwan expect good uptake of SGLT-2 inhibitors

Physicians in South Korea and Taiwan expect good uptake of SGLT-2 inhibitors

20-10-2014

Prescribers are enthusiastic about the emergence of SGLT2-2 inhibitors for type 2 diabetes, but payers…

AbasriaAsia-PacificDiabetesLantusPharmaceuticalResearch

Age is a factor when looking at diabetes management, Sanofi survey finds

Age is a factor when looking at diabetes management, Sanofi survey finds

15-10-2014

The US subsidiary of French pharma major Sanofi has announced the findings of a new survey that reveals…

DiabetesPharmaceuticalResearchSanofiUSA

Boehringer Ingelheim gets two drugs approved by Scotland’s health watchdog

14-10-2014

The UK subsidiary of German family-owned pharma major Boehringer Ingelheim announced today that, following…

Boehringer IngelheimCardio-vascularDiabetesJardiancePharmaceuticalPradaxaPricingUK

Ultra-rapid-acting insulin formulations will revolutionize type 1 diabetes market by 2019

Ultra-rapid-acting insulin formulations will revolutionize type 1 diabetes market by 2019

08-10-2014

Ultra-rapid formulations of the currently marketed rapid-acting insulin analogs have the clear potential…

AdociaBioChaperoneDiabetesFIAspGlobalMarkets & MarketingNovo NordiskPharmaceuticalResearch

1 to 25 of 405 results

Back to top